Interestingly, S100A2 and GNA15 prognostic values are significant in a subset of PAAD patients initially diagnosed by cytology (e.g. peritoneal or pleural fluid, Supp. The gene discussed is S100A2; the disease is pancreatic adenocarcinoma.